Cross Infection: Clinical Trials

38 trials for Cross Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed. 38 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 438Completed 38

Follow Cross Infection: new trials by email Literature Review of Cross Infection trials Research Report on Cross Infection

Trials (filtered) newest first · largest first

All 38 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia
Amikacin (Inhalation), Standard-of-Care Intravenous Antibiotics - Ventilator Associated Pneumonia ( VAP)
Phase 4CompletedPostgraduate Medical Institute, Lahore902024-01-052026-01-27
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
Ambroxol Hydrochloride, Standard Therapy - Severe Pneumonia, Community-acquired Pneumonia
Phase 4CompletedNational University of Malaysia322023-01-072023-12-27
Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
Tranexamic Acid, Placebos - Infection Wound, Gastrointestinal Complication
Phase 4CompletedBayside Health33002022-05-182025-12-31
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
Zavicefta, Ceftazidime-Avibactam, Best Available Treatment - Urinary Tract Infection, Acute Pyelonephritis
Phase 4CompletedPfizer602021-08-262024-10-21
Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)
Zavicefta, Ceftazidime-Avibactam - Hospital-Acquired Pneumonia
Phase 4CompletedPfizer2352021-05-212024-09-19
Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia
Simvastatin - VAP - Ventilator Associated Pneumonia
Phase 4CompletedAin Shams University1612021-01-012022-02-09
Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District
Engerix-B - Hepatitis B Virus, Health Care Associated Infection
Phase 4CompletedCentre for Infectious Disease Research in Zambia6412019-11-252026-08-10
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier] - Hepatitis C, Hemodialysis
Phase 4CompletedUniversity of Pennsylvania62019-09-222021-12-15
VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs
ETTEvac, BIP ETTEvac - Ventilator-associated Pneumonia
Phase 4CompletedBactiguard AB3232018-10-312021-01-20
GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial
Gram stain-guided antibiotic choice, Guidelines-based antibiotics choice - Ventilator Associated Pneumonia
Phase 4CompletedOsaka General Medical Center2062018-04-012022-09-21
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
Arm 1. Routine Care (Mupirocin/CHG), Arm 2. Iodophor/CHG Decolonization - Staphylococcus Aureus
Phase 4CompletedHarvard Pilgrim Health Care3533232017-05-012025-03-30
4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings
4% chlorhexidine gluconate soap-like solution, standard soap - Hospital Infection
Phase 4CompletedUniversity Of Perugia4492015-08-102018-08-21
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
L. rhamnosus GG - Probiotic, Placebo - Microcrystalline Cellulose - Ventilator Associated Pneumonia, Infections
Phase 4CompletedMcMaster University26502015-06-012020-12-17
Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia
tobramycin inhalation, placebo - Ventilator Associated Pneumonia (VAP)
Phase 4CompletedErasmus Medical Center802015-03-012021-08-18
BIP CVC Clinical Safety and Performance Study
BIP CVC, Uncoated Standard CVC - Surgery, Central Line Associated Blood Stream Infections (CLABSI)
Phase 4CompletedBactiguard AB362013-09-012016-06-23
Common Canister Protocol for Inhaler Administration in Mechanically Ventilated Patients
Common canister - Ventilator Associated Pneumonia
Phase 4CompletedBarnes-Jewish Hospital3542013-06-012016-10-07
Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
AS colistin and "imipenem", IV colistin " and "imipenem" ., AS colimycin (colistin) - Pneumonia, Ventilator-Associated
Phase 4CompletedTunis University1332013-04-012016-02-17
Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
Chlorhexidine bathing, Non-chlorhexidine bathing - Healthcare Associated Infections
Phase 4CompletedVanderbilt University120002012-07-012014-01-10
Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia
Imipenem - Ventilator Associated Pneumonia
Phase 4CompletedPrince of Songkla University82011-11-012017-09-20
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
Doripenem - Ventilator-Associated Pneumonia
Phase 4CompletedSutep Jaruratanasirikul122010-10-012011-11-09

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Pneumonia, Ventilator-Associated (24)  ·  Healthcare-Associated Pneumonia (7)  ·  Infections (4)  ·  Critical Illness (3)  ·  Intraabdominal Infections (3)  ·  Pneumonia (3)  ·  Urinary Tract Infections (3)  ·  Sepsis (2)  ·  Staphylococcal Infections (2)  ·  Appendicitis (1)  ·  Asthma (1)  ·  Bacteremia (1)  ·  Bacterial Infections (1)  ·  Cholecystitis (1)

Broader conditions

Disease Attributes (38)  ·  Iatrogenic Disease (38)  ·  Pathologic Processes (38)  ·  Pathological Conditions, Signs and Symptoms (38)  ·  Infections (34)  ·  Lung Diseases (27)  ·  Respiratory Tract Diseases (27)  ·  Respiratory Tract Infections (27)  ·  Pneumonia (24)  ·  Healthcare-Associated Pneumonia (20)  ·  Bacterial Infections and Mycoses (5)  ·  Bacterial Infections (4)  ·  Digestive System Diseases (3)  ·  Female Urogenital Diseases (3)

Interventions

Doripenem (3)  ·  Imipenem (3)  ·  Ceftriaxone (2)  ·  Inhalation (2)  ·  Linezolid (2)  ·  Vancomycin (2)  ·  avibactam, ceftazidime drug combination (2)  ·  Ambroxol (1)  ·  Amikacin (1)  ·  Amoxicillin (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Arginine (1)  ·  Cefotaxime (1)  ·  Chlorhexidine (1)  ·  Cilastatin, Imipenem Drug Combination (1)

Sponsors

Pfizer (4)  ·  Sutep Jaruratanasirikul (3)  ·  Bactiguard AB (2)  ·  Hospital Universitario de Canarias (2)  ·  Ain Shams University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Barnes-Jewish Hospital (1)  ·  Bayside Health (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Centre for Infectious Disease Research in Zambia (1)  ·  Erasmus Medical Center (1)  ·  Harvard Pilgrim Health Care (1)  ·  Janssen Research & Development, LLC (1)  ·  Janssen-Cilag Ltd.,Thailand (1)  ·  King Edward Memorial Hospital (1)

Countries

United States (9)  ·  Thailand (5)  ·  France (4)  ·  Malaysia (3)  ·  Spain (3)  ·  Argentina (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Canada (2)  ·  Chile (2)  ·  China (2)  ·  Germany (2)  ·  Greece (2)  ·  Hong Kong (2)  ·  India (2)

Top investigators

Sutep Jaruratanasirikul, MD (3)  ·  Ahlem Trifi (1)  ·  Apostolos Armaganidis, MD, PhD (1)  ·  Benoit Misset, MD,Prof. (1)  ·  Charis Roussos, MD, PhD (1)  ·  Christof von Eiff, MD (1)  ·  Deborah J Cook, MD (1)  ·  Dilip R Karnad, MD,FACP,FRCP (1)  ·  Evangelos J Giamarellos-Bourboulis, MD, PhD (1)  ·  Helen Giamarellou, MD, PhD (1)

Results publications

PMID 17872488, PMID 17954800, PMID 18626628, PMID 18707849, PMID 18719064, PMID 20670293, PMID 22422274, PMID 22483191, PMID 22952580, PMID 23778831, PMID 24011955, PMID 24279701, PMID 24636429, PMID 25602496, PMID 26196695, PMID 27033711, PMID 27044546, PMID 27143787, PMID 27600290, PMID 29741298, PMID 30267930, PMID 30409160, PMID 31227528, PMID 31783881, PMID 34546300, PMID 34871241, PMID 34981245, PMID 35394515, PMID 35724443, PMID 36682909, PMID 37815567, PMID 39731129, PMID 41013603, PMID 41248372, PMID 42829121

NIH funding

2014 (1)